Cargando…
Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
The recent outbreak of the novel coronavirus disease, COVID-19, has highlighted the threat that highly pathogenic coronaviruses have on global health security and the imminent need to design an effective vaccine for prevention purposes. Although several attempts have been made to develop vaccines ag...
Autor principal: | Khalaj-Hedayati, Atin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368938/ https://www.ncbi.nlm.nih.gov/pubmed/32695833 http://dx.doi.org/10.1155/2020/7201752 |
Ejemplares similares
-
Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement
por: Khalaj‐Hedayati, Atin, et al.
Publicado: (2019) -
Protection against infectious bronchitis virus by spike ectodomain subunit vaccine
por: Eldemery, Fatma, et al.
Publicado: (2017) -
Coronavirus vaccine protects against SARS
Publicado: (2013) -
A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
por: Wu, Yangtao, et al.
Publicado: (2021) -
Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)